Silybum marianumFinding
Silybum marianum decreases aspartate aminotransferase
lowersModerate evidenceFindingreplicated ×1
01 · The sentence it was drawn from
“At day 56, the MT group had lower AST than the placebo group (p= 0.04).”
Silybum marianum
Aspartate aminotransferase
lowers
- Who
- children aged 1-21 with acute lymphoblastic leukaemia in maintenance chemotherapy with grade 2 or higher hepatic toxicity; AST at day 56, four weeks after the 28-day course ended
- Dose studied
- silibinin target 5.1 mg/kg/day by weight band (80, 160, 240 or 320 mg/day), by mouth daily for 28 days
Moderate evidencePMID 20014183 · 2010
02 · The study
- Study
- RCT
- Duration
- 4 weeks
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Cancer04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7FQ383PHS9FCC6PFAD60ZQJ